---
title: "Tyra Bioscience (TYRA) Receives a Buy from Oppenheimer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290051032.md"
description: "Oppenheimer analyst Matthew Biegler maintained a Buy rating on Tyra Bioscience (TYRA) with a $50 price target. Additionally, JonesTrading initiated coverage with a Buy rating and a $56 price target."
datetime: "2026-06-17T11:57:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290051032.md)
  - [en](https://longbridge.com/en/news/290051032.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290051032.md)
generator: "portal-rs"
---

# Tyra Bioscience (TYRA) Receives a Buy from Oppenheimer

In a report released today, Matthew Biegler from Oppenheimer maintained a Buy rating on Tyra Bioscience, with a price target of $50.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Biegler is a 3-star analyst with an average return of 1.3% and a 37.72% success rate. Biegler covers the Healthcare sector, focusing on stocks such as Gilead Sciences, Biomea Fusion, and Relay Therapeutics.

In a report released today, JonesTrading also initiated coverage with a Buy rating on the stock with a $56.00 price target.

### Related Stocks

- [TYRA.US](https://longbridge.com/en/quote/TYRA.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [BMEA.US](https://longbridge.com/en/quote/BMEA.US.md)
- [RLAY.US](https://longbridge.com/en/quote/RLAY.US.md)

## Related News & Research

- [Tyra Biosciences: Buy Rating Reiterated as SURF302 Data Upside Beckons; 12‑Month Price Target Maintained at $45](https://longbridge.com/en/news/298055291.md)
- [Tyra Biosciences to present initial Phase 2 SURF302 data for oral dabogratinib in intermediate-risk bladder cancer on Sept. 9](https://longbridge.com/en/news/298034950.md)
- [TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY | TYRA Stock News](https://longbridge.com/en/news/287215316.md)
- [Walleye Capital LLC Acquires Shares of 347,898 Tyra Biosciences, Inc. $TYRA](https://longbridge.com/en/news/295998857.md)
- [TipRanks Analyst Salveen Richter Reiterates Buy on Braveheart Bio, Sets $48 12-Month Target on Strong HCM Opportunity for Lead Asset BHB-1893](https://longbridge.com/en/news/297471640.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**